Surface markers of lymphocyte activation and markers of cell proliferation

Clicks: 316
ID: 268216
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #8 of 9 articles by views in clinica chimica acta; international journal of clinical chemistry

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The individualization of immunosuppression is an approach for preventing rejection in the early phase after transplantation and for avoiding the long-term side effects of over immunosuppression. Pharmacodynamic markers, either specific or nonspecific, have been proposed as complementary tools to dru …
Reference Key
m2012clinicasurface Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shipkova M;Wieland E;;
Journal clinica chimica acta; international journal of clinical chemistry
Year 2012
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/22120733
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine biomarkers / analysis biomarkers / metabolism cell proliferation pmid:22120733 doi:10.1016/j.cca.2011.11.006 maria shipkova eberhard wieland cell membrane / metabolism* lymphocytes / cytology* lymphocytes / metabolism*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.